| # | Title | Journal | Year | Citations |
|---|
| 1 | Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology | Journal of Psychopharmacology | 2016 | 755 |
| 2 | Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies | BMJ, The | 2014 | 298 |
| 3 | Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation | British Journal of Psychiatry | 2012 | 280 |
| 4 | The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal | Therapeutic Advances in Psychopharmacology | 2014 | 224 |
| 5 | Practitioner attitudes to clozapine initiation | Acta Psychiatrica Scandinavica | 2014 | 105 |
| 6 | Shifting brain inhibitory balance and connectivity of the prefrontal cortex of adults with autism spectrum disorder | Translational Psychiatry | 2017 | 101 |
| 7 | Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy | Acta Psychiatrica Scandinavica | 2007 | 92 |
| 8 | Reasons for discontinuing clozapine: matched, case–control comparison with risperidone long-acting injection | British Journal of Psychiatry | 2009 | 90 |
| 9 | Augmentation of clozapine with a second antipsychotic – a meta‐analysis of randomized, placebo‐controlled studies | Acta Psychiatrica Scandinavica | 2009 | 87 |
| 10 | Restarting Clozapine after Neutropenia | CNS Drugs | 2007 | 85 |
| 11 | Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy | British Journal of Psychiatry | 2011 | 72 |
| 12 | Amisulpride – dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring | Acta Psychiatrica Scandinavica | 2009 | 66 |
| 13 | Quality of prescribing for schizophrenia: Evidence from a national audit in England and Wales | European Neuropsychopharmacology | 2014 | 64 |
| 14 | Identification of Adverse Drug Events from Free Text Electronic Patient Records and Information in a Large Mental Health Case Register | PLoS ONE | 2015 | 62 |
| 15 | Olanzapine | Journal of Clinical Psychopharmacology | 2013 | 56 |
| 16 | A decision analysis of long‐term lithium treatment and the risk of renal failure | Acta Psychiatrica Scandinavica | 2012 | 55 |
| 17 | A review of the adverse effects and safety of noradrenergic antidepressants | Journal of Psychopharmacology | 2013 | 50 |
| 18 | Once-monthly paliperidone injection for the treatment of schizophrenia | Neuropsychiatric Disease and Treatment | 2010 | 44 |
| 19 | ADEPt, a semantically-enriched pipeline for extracting adverse drug events from free-text electronic health records | PLoS ONE | 2017 | 41 |
| 20 | Relationship Between Daily Dose, Plasma Concentrations, Dopamine Receptor Occupancy, and Clinical Response to Quetiapine | Journal of Clinical Psychiatry | 2011 | 39 |
| 21 | Comparative Effectiveness of Atypical Antipsychotics in Schizophrenia | CNS Drugs | 2012 | 38 |
| 22 | Antipsychotic polypharmacy – confusion reigns | The Psychiatrist | 2010 | 36 |
| 23 | Aripiprazole | CNS Drugs | 2009 | 35 |
| 24 | Clozapine in the treatment of refractory schizophrenia: a practical guide for healthcare professionals | British Medical Bulletin | 2020 | 34 |
| 25 | Management of clozapine treatment during the COVID-19 pandemic | Therapeutic Advances in Psychopharmacology | 2020 | 34 |
| 26 | The importance of the recognition of benign ethnic neutropenia in black patients during treatment with clozapine: case reports and database study | Journal of Psychopharmacology | 2011 | 33 |
| 27 | 'As required' medication regimens for seriously mentally ill people in hospital | The Cochrane Library | 2015 | 31 |
| 28 | Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder | Neuropsychiatric Disease and Treatment | 2009 | 30 |
| 29 | Reducing the rates of prescribing high-dose antipsychotics and polypharmacy on psychiatric inpatient and intensive care units: results of a 6-year quality improvement programme | Therapeutic Advances in Psychopharmacology | 2015 | 29 |
| 30 | The side effect profile of Clozapine in real world data of three large mental health hospitals | PLoS ONE | 2020 | 28 |
| 31 | Is paliperidone palmitate more effective than other long-acting injectable antipsychotics? | Psychological Medicine | 2018 | 26 |
| 32 | There Is Life After the UK Clozapine Central Non-Rechallenge Database | Schizophrenia Bulletin | 2021 | 24 |
| 33 | The anticholinergic effect on cognition ( AEC ) scale—Associations with mortality, hospitalisation and cognitive decline following dementia diagnosis | International Journal of Geriatric Psychiatry | 2020 | 22 |
| 34 | Clozapine haematological monitoring for neutropenia: a global perspective | Epidemiology and Psychiatric Sciences | 2022 | 21 |
| 35 | Point-of-care measurement of clozapine concentration using a finger-stick blood sample | Journal of Psychopharmacology | 2021 | 18 |
| 36 | Antipsychotic prescribing – time to review practice | Psychiatric Bulletin | 2002 | 16 |
| 37 | Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review | Therapeutic Advances in Psychopharmacology | 2022 | 16 |
| 38 | Prescribing according to diagnosis: how psychiatry is different | World Psychiatry | 2016 | 15 |
| 39 | Variation in dose and plasma level of lamotrigine in patients discharged from a mental health trust | Therapeutic Advances in Psychopharmacology | 2017 | 15 |
| 40 | The effect of COVID-19 on absolute neutrophil counts in patients taking clozapine | Therapeutic Advances in Psychopharmacology | 2020 | 15 |
| 41 | Clozapine-induced myoclonus: a case report and review of the literature | Therapeutic Advances in Psychopharmacology | 2015 | 13 |
| 42 | Factors associated with changes in hospitalisation in patients prescribed clozapine | Journal of Psychopharmacology | 2016 | 13 |
| 43 | Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unit | Therapeutic Advances in Psychopharmacology | 2017 | 12 |
| 44 | Aripiprazole: A Review of its Use in the Treatment of Irritability Associated with Autistic Disorder Patients Aged 6-17 | Journal of Central Nervous System Disease | 2011 | 11 |
| 45 | Estimating the optimal dose of flupentixol decanoate in the maintenance treatment of schizophrenia—a systematic review of the literature | Psychopharmacology | 2019 | 11 |
| 46 | Long-term follow-up of clozapine prescribing | Journal of Psychopharmacology | 2018 | 10 |
| 47 | Newer Formulations of Risperidone: Role in the Management of Psychotic Disorders | CNS Drugs | 2020 | 10 |
| 48 | Resolution without discontinuation: heart failure during clozapine treatment | Therapeutic Advances in Psychopharmacology | 2020 | 10 |
| 49 | Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitals | BMC Psychiatry | 2021 | 10 |
| 50 | Use of Antacid Medication in Patients Receiving Clozapine | Journal of Clinical Psychopharmacology | 2010 | 9 |
